Last reviewed · How we verify
NCT02909387
Adapting Project UPLIFT for Blacks in Georgia
NA trial testing Project UPLIFT in Epilepsy in 82 participants. Completed in 30 September 2019.
30 September 2019
Quick facts
| Lead sponsor | Morehouse School of Medicine |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 82 |
| Start date | 8 September 2016 |
| Primary completion | 30 September 2019 |
| Estimated completion | 30 September 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Project UPLIFT
Conditions studied
- Epilepsy — all drugs for Epilepsy →
- Depressive Symptoms — all drugs for Depressive Symptoms →
- Anxiety Disorders and Symptoms — all drugs for Anxiety Disorders and Symptoms →
Sponsor
Morehouse School of Medicine
Who can join
18 and older, any sex, with Epilepsy or Depressive Symptoms. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Evaluate the efficacy of Project UPLIFT for reducing symptoms of depression and anxiety among African Americans at immediate posttest and after 3 months.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02909387
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Project UPLIFT
Trials testing the same drug.
- NCT06865820 — Implementation and Cost Evaluation of Project UPLIFT · NA · recruiting
- NCT03329703 — Project UPLIFT for Psychogenic Non-Epileptic Seizures · NA · completed
Other recruiting trials for Epilepsy
Currently open trials in the same condition.
- NCT07095933 — The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy · EARLY_PHASE1 · recruiting
- NCT07224191 — Hippocampal Oscillations During Exploration · NA · recruiting
- NCT07219407 — A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures · Phase 2 · recruiting
- NCT07417280 — LIFUS For Neurological Disorders · NA · recruiting
- NCT07490769 — Levetiracetam Three Times Daily in Epilepsy · Phase 3 · recruiting
Other Morehouse School of Medicine trials
Trials by the same sponsor.
- NCT07441655 — Families Implementing Good Health Traditions for Life · NA · recruiting
- NCT06926855 — Community Health Workers Reduce Social Barriers That Affect the Health of Patients With High Blood Pressure and Diabetes · NA · active not recruiting
- NCT06229275 — Comparing Effectiveness of Physician-assisted Versus Self-assisted Pap Smear Collection · NA · recruiting
- NCT05863884 — RADx-UP- Impact of Community Health Worker Deployment · NA · completed
- NCT03890029 — G.R.I.T. - Goal-directed Resilience Intervention Training · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02909387 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Morehouse School of Medicine
- Last refreshed: 23 June 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02909387.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing